IMPORTANT LEGAL NOTICE - The information on this site is subject to a disclaimer and a copyright notice.
European Flag    Europa Graphic element The European Commission Graphic element ResearchGraphic elementWhat is Europe doing?
What is Europe doing?

Diabetes and cardiovascular disease

Previous Contents Next
Previous Contents Next

Graphic elementThe facts

Diabetes and cardiovascular diseaseDiabetes and heart disease are two of the world's most common chronic diseases.
More than 10 million people in Europe have diabetes. Many sufferers who develop the disease in middle age can control their symptoms by watching what they eat. The diabetes that strikes young people is often more severe, and can be fatal without regular insulin injections. Even with good treatment, diabetics of all types are prone to distressing long term health problems.
Cardiovascular diseases cause 12 million deaths per year world-wide and account for more than half of all deaths in Europe of people over 65. The wide variation in the incidence of heart disease between European countries is causing great concern; in France, four people in every 10 000 die prematurely from heart disease but in Latvia the death rate for people under 65 is more than six times higher.

Graphic elementAction

Diabetes and cardiovascular diseaseBoth diabetes and heart disease occur in various forms and are caused by a mixture of factors, some genetic, some environmental. Unravelling exactly what causes particular types of these common diseases requires the skills of scientists from many different areas. Europe is funding large projects to bring scientists with the right backgrounds together and also make use of the huge natural resource offered by a total population of 370 million people. European researchers have also set up international projects that are receiving world recognition for their efforts.

International Stroke Trial - Aspirin against heart attack
Several European research projects have identified simple treatments that can be taken by people at risk from cardiovascular disease. Two multinational studies have found that people who have recently suffered a heart attack or a stroke benefit from taking regular small doses of aspirin to prevent further blood clots. The International Stroke Trial, the world's largest ever trial of this type, involved 20000 patients from 600 hospitals in 43 countries.

Diabetes and cardiovascular disease

EURODIAB - Understanding the causes of childhood diabetes
The number of young people in Europe who develop childhood diabetes is still rising. Currently, central and eastern European countries are seeing the greatest increase in cases. Children who develop diabetes can be treated with insulin but they must learn to cope with daily injections and often suffer ill health later in life. EURODIAB TIGER and its predecessor EURODIAB ACE are making use of a large registration network developed during the last 15 years to look for the causes of the disease. This is a crucial step towards being able to prevent childhood diabetes in future generations.

Diabetes and cardiovascular disease

U-CARE - Preventing atypical cardiac arrests
Even young people in good health can be the victims of cardiac arrest. The
U-CARE (Unexplained Cardiac Arrest Registry of Europe) project studied people who recovered after emergency treatment for cardiac arrest. Patients from five different countries were checked yearly for ten years. One of the aims of U-CARE was to find out which drugs and treatments given after the heart attack were the most useful.

Previous Contents Next
Previous Contents Next
  Graphic element Search Top